Therapeutic vaccination against a murine lymphoma by intratumoral injection of a cationic anticancer peptide

Cancer Immunology, Immunotherapy

Volumn 59, Issue 8, 2010, Pages 1285-1294

  Berge, Gerd ^a   Eliassen, Liv Tone ^a,b   Camilio, Ketil Andre ^a,b   Bartnes, Kristian ^c   Sveinbjørnsson, Baldur ^a,d   Rekdal, Øystein ^a,b  

^a UNIVERSITY OF TROMSØ   (Norway)

^b LYTIX BIOPHARMA AS   (Norway)

^c UNIVERSITY HOSPITAL OF NORTH NORWAY   (Norway)

^d KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Cationic antimicrobial peptide; Immunotherapy; Lymphoma; Necrosis; Tumor vaccine

Indexed keywords

ANTIMICROBIAL CATIONIC PEPTIDE; ANTIMICROBIAL CATIONIC PEPTIDE LTX 302; UNCLASSIFIED DRUG;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; B CELL LYMPHOMA; BAGG ALBINO MOUSE; CANCER CONTROL; CANCER REGRESSION; CANCER RESISTANCE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CONTROLLED STUDY; DRUG CYTOTOXICITY; ERYTHROCYTE; HUMAN; HUMAN CELL; INFLAMMATORY INFILTRATE; LONG TERM CARE; MOUSE; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; SINGLE DRUG DOSE; T CELL DEPLETION; T LYMPHOCYTE; TUMOR NECROSIS;

ADOPTIVE TRANSFER; ANIMALS; ANTIMICROBIAL CATIONIC PEPTIDES; CANCER VACCINES; CATTLE; CELL LINE, TUMOR; FEMALE; HMGB1 PROTEIN; LACTOFERRIN; LYMPHOCYTE ACTIVATION; LYMPHOCYTE DEPLETION; LYMPHOMA, B-CELL; MICE; MICE, INBRED BALB C; MICROSCOPY, ELECTRON, SCANNING; NEOPLASM TRANSPLANTATION; PEPTIDE FRAGMENTS; REMISSION INDUCTION; T-LYMPHOCYTES; TUMOR BURDEN;

EID: 77953207726     PISSN: 03407004     EISSN: 14320851     Source Type: Journal    
DOI: 10.1007/s00262-010-0857-6     Document Type: Article

References (41)

1. DW Hoskin A Ramamoorthy 2008 Studies on anticancer activities of antimicrobial peptides Biochim Biophys Acta 1778 357 375 10.1016/j.bbamem.2007. 11.008 1:CAS:528:DC%2BD1cXpt1OnsA%3D%3D 18078805
2. JS Mader DW Hoskin 2006 Cationic antimicrobial peptides as novel cytotoxic agents for cancer treatment Expert Opin Investig Drugs 15 933 946 10.1517/13543784.15.8.933 1:CAS:528:DC%2BD28Xnt1ahsbk%3D 16859395 (Pubitemid 44177845)
3. N Papo Y Shai 2005 Host defense peptides as new weapons in cancer treatment Cell Mol Life Sci 62 784 790 10.1007/s00018-005-4560-2 1:CAS:528:DC%2BD2MXmvVyks74%3D 15868403 (Pubitemid 40655628)
4. T Iwasaki J Ishibashi H Tanaka M Sato A Asaoka D Taylor M Yamakawa 2009 Selective cancer cell cytotoxicity of enantiomeric 9-mer peptides derived from beetle defensins depends on negatively charged phosphatidylserine on the cell surface Peptides 30 660 668 10.1016/j.peptides.2008.12.019 1:CAS:528: DC%2BD1MXjvVWhtbo%3D 19154767
5. T Utsugi AJ Schroit J Connor CD Bucana IJ Fidler 1991 Elevated expression of phosphatidylserine in the outer membrane leaflet of human tumor cells and recognition by activated human blood monocytes Cancer Res 51 3062 3066 1:CAS:528:DyaK3MXkt1Kqtrw%3D 2032247
6. I Dobrzynska B Szachowicz-Petelska S Sulkowski Z Figaszewski 2005 Changes in electric charge and phospholipids composition in human colorectal cancer cells Mol Cell Biochem 276 113 119 10.1007/s11010-005-3557-3 1:CAS:528:DC%2BD2MXnsl2hs7c%3D 16132692 (Pubitemid 41236216)
7. MD Burdick A Harris CJ Reid T Iwamura MA Hollingsworth 1997 Oligosaccharides expressed on MUC1 produced by pancreatic and colon tumor cell lines J Biol Chem 272 24198 24202 10.1074/jbc.272.39.24198 1:CAS:528: DyaK2sXmsFanu7g%3D 9305871 (Pubitemid 27418619)
8. WH Yoon HD Park K Lim BD Hwang 1996 Effect of O-glycosylated mucin on invasion and metastasis of HM7 human colon cancer cells Biochem Biophys Res Commun 222 694 699 10.1006/bbrc.1996.0806 1:CAS:528:DyaK28XjtlKlt7o%3D 8651907 (Pubitemid 26194814)
9. JS Mader J Salsman DM Conrad DW Hoskin 2005 Bovine lactoferricin selectively induces apoptosis in human leukemia and carcinoma cell lines Mol Cancer Ther 4 612 624 10.1158/1535-7163.MCT-04-0077 1:CAS:528: DC%2BD2MXjtFegsLw%3D 15827335 (Pubitemid 40601843)
10. Y Chen X Xu S Hong J Chen N Liu CB Underhill K Creswell L Zhang 2001 RGD-Tachyplesin inhibits tumor growth Cancer Res 61 2434 2438 1:CAS:528:DC%2BD3MXisVSlu74%3D 11289111
11. HM Ellerby W Arap LM Ellerby R Kain R Andrusiak GD Rio S Krajewski CR Lombardo R Rao E Ruoslahti DE Bredesen R Pasqualini 1999 Anti-cancer activity of targeted pro-apoptotic peptides Nat Med 5 1032 1038 10.1038/12469 1:CAS:528:DyaK1MXlslGqtLs%3D 10470080 (Pubitemid 29439574)
12. A Risso E Braidot MC Sordano A Vianello F Macri B Skerlavaj M Zanetti R Gennaro P Bernardi 2002 BMAP-28, an antibiotic peptide of innate immunity, induces cell death through opening of the mitochondrial permeability transition pore Mol Cell Biol 22 1926 1935 10.1128/MCB.22.6.1926-1935.2002 1:CAS:528:DC%2BD38XitVWjur8%3D 11865069 (Pubitemid 34175007)
13. S Kim SS Kim YJ Bang SJ Kim BJ Lee 2003 In vitro activities of native and designed peptide antibiotics against drug sensitive and resistant tumor cell lines Peptides 24 945 953 10.1016/S0196-9781(03)00194-3 1:CAS:528: DC%2BD3sXnt1Grt74%3D 14499271 (Pubitemid 37130165)
14. FJ Sharom G DiDiodato X Yu KJ Ashbourne 1995 Interaction of the P-glycoprotein multidrug transporter with peptides and ionophores J Biol Chem 270 10334 10341 10.1074/jbc.270.17.10334 1:CAS:528:DyaK2MXltlWntrc%3D 7730340
15. SA Johnstone K Gelmon LD Mayer RE Hancock MB Bally 2000 In vitro characterization of the anticancer activity of membrane-active cationic peptides. I. Peptide-mediated cytotoxicity and peptide-enhanced cytotoxic activity of doxorubicin against wild-type and p-glycoprotein over-expressing tumor cell lines Anticancer Drug Des 15 151 160 1:CAS:528:DC%2BD3cXkvVymsb4%3D 10901303
16. LT Eliassen G Berge A Leknessund M Wikman I Lindin C Lokke F Ponthan JI Johnsen B Sveinbjornsson P Kogner T Flaegstad O Rekdal 2006 The antimicrobial peptide, lactoferricin B, is cytotoxic to neuroblastoma cells in vitro and inhibits xenograft growth in vivo Int J Cancer 119 493 500 10.1002/ijc.21886 1:CAS:528:DC%2BD28Xmtlyjsr8%3D 16572423 (Pubitemid 43955700)
17. LT Eliassen G Berge B Sveinbjornsson JS Svendsen LH Vorland O Rekdal 2002 Evidence for a direct antitumor mechanism of action of bovine lactoferricin Anticancer Res 22 2703 2710 1:CAS:528:DC%2BD3sXoslyruw%3D%3D 12529985
18. YC Yoo S Watanabe R Watanabe K Hata K Shimazaki I Azuma 1997 Bovine lactoferrin and lactoferricin, a peptide derived from bovine lactoferrin, inhibit tumor metastasis in mice Jpn J Cancer Res 88 184 190 1:CAS:528:DyaK2sXhs1Krsr4%3D 9119747
19. LT Eliassen BE Haug G Berge O Rekdal 2003 Enhanced antitumour activity of 15-residue bovine lactoferricin derivatives containing bulky aromatic amino acids and lipophilic N-terminal modifications J Pept Sci 9 510 517 10.1002/psc.472 1:CAS:528:DC%2BD3sXms1Wjsbg%3D 12952392 (Pubitemid 37009928)
20. N Yang T Lejon O Rekdal 2003 Antitumour activity and specificity as a function of substitutions in the lipophilic sector of helical lactoferrin-derived peptide J Pept Sci 9 300 311 10.1002/psc.457 1:CAS:528:DC%2BD3sXkvVeku7w%3D 12803496 (Pubitemid 36665526)
21. N Yang W Stensen JS Svendsen O Rekdal 2002 Enhanced antitumor activity and selectivity of lactoferrin-derived peptides J Pept Res 60 187 197 10.1034/j.1399-3011.2002.21008.x 1:CAS:528:DC%2BD38Xnsl2ltrc%3D 12366526 (Pubitemid 35155428)
22. N Yang MB Strom SM Mekonnen JS Svendsen O Rekdal 2004 The effects of shortening lactoferrin derived peptides against tumour cells, bacteria and normal human cells J Pept Sci 10 37 46 10.1002/psc.470 1:CAS:528: DC%2BD2cXhsFKktr4%3D 14959890 (Pubitemid 38100727)
23. MB Strom O Rekdal JS Svendsen 2000 Antibacterial activity of 15-residue lactoferricin derivatives J Pept Res 56 265 274 10.1034/j.1399-3011.2000.00770.x 1:CAS:528:DC%2BD3cXnvVGltb0%3D 11095180
24. KJ Kim C Kanellopoulos-Langevin RM Merwin DH Sachs R Asofsky 1979 Establishment and characterization of BALB/c lymphoma lines with B cell properties J Immunol 122 549 554 1:STN:280:DyaE1M7htVKmtw%3D%3D 310843
25. B Sveinbjornsson R Olsen OM Seternes R Seljelid 1996 Macrophage cytotoxicity against murine meth A sarcoma involves nitric oxide-mediated apoptosis Biochem Biophys Res Commun 223 643 649 10.1006/bbrc.1996.0948 1:STN:280:DyaK283mvVOgsA%3D%3D 8687449 (Pubitemid 26246126)
26. T Mosmann 1983 Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays J Immunol Methods 65 55 63 10.1016/0022-1759(83)90303-4 1:STN:280:DyaL2c%2FovFSmtw%3D%3D 6606682
27. Bozzola JJ, Russell LD (1992) Specimen preparation for scanning electron microscopy. In: Electron microscopy: principles and techniques for biologists. Jones and Bartlett Publishers, Boston, pp 48-69
28. Bozzola JJ, Russell LD. 1992. Specimen preparation for transmission electron microscopy. In: Electron microscopy: principles and techniques for biologists. Jones and Bartlett Publishers, Boston, pp 16-45
29. P Scaffidi T Misteli ME Bianchi 2002 Release of chromatin protein HMGB1 by necrotic cells triggers inflammation Nature 418 191 195 10.1038/nature00858 1:CAS:528:DC%2BD38XltFGlsro%3D 12110890 (Pubitemid 34773774)
30. C Leuschner FM Enright B Gawronska W Hansel 2003 Membrane disrupting lytic peptide conjugates destroy hormone dependent and independent breast cancer cells in vitro and in vivo Breast Cancer Res Treat 78 17 27 10.1023/A:1022169525521 1:CAS:528:DC%2BD3sXntV2rsA%3D%3D 12611453 (Pubitemid 36223013)
31. N Papo D Seger A Makovitzki V Kalchenko Z Eshhar H Degani Y Shai 2006 Inhibition of tumor growth and elimination of multiple metastases in human prostate and breast xenografts by systemic inoculation of a host defense-like lytic peptide Cancer Res 66 5371 5378 10.1158/0008-5472.CAN-05-4569 1:CAS:528:DC%2BD28XksF2isbg%3D 16707464 (Pubitemid 43844963)
32. N Papo A Braunstein Z Eshhar Y Shai 2004 Suppression of human prostate tumor growth in mice by a cytolytic d-, l-amino acid peptide: membrane lysis, increased necrosis, and inhibition of prostate-specific antigen secretion Cancer Res 64 5779 5786 10.1158/0008-5472.CAN-04-1438 1:CAS:528:DC%2BD2cXmslaksrs%3D 15313920 (Pubitemid 39095578)
33. PW Soballe WL Maloy ML Myrga LS Jacob M Herlyn 1995 Experimental local therapy of human melanoma with lytic magainin peptides Int J Cancer 60 280 284 10.1002/ijc.2910600225 1:STN:280:DyaK2M7jtVantw%3D%3D 7829229
34. MA Baker WL Maloy M Zasloff LS Jacob 1993 Anticancer efficacy of magainin2 and analogue peptides Cancer Res 53 3052 3057 1:CAS:528: DyaK3sXlsleksLw%3D 8319212
35. EG Rodrigues AS Dobroff CF Cavarsan T Paschoalin L Nimrichter RA Mortara EL Santos MA Fazio A Miranda S Daffre LR Travassos 2008 Effective topical treatment of subcutaneous murine B16F10-Nex2 melanoma by the antimicrobial peptide gomesin Neoplasia 10 61 68 10.1593/neo.07885 1:CAS:528: DC%2BD1cXltleis7s%3D 18231639 (Pubitemid 351170713)
36. JC Mai Z Mi SH Kim B Ng PD Robbins 2001 A proapoptotic peptide for the treatment of solid tumors Cancer Res 61 7709 7712 1:CAS:528:DC%2BD3MXotlaktb8%3D 11691780
37. MH den Brok RP Sutmuller R van der Voort EJ Bennink CG Figdor TJ Ruers GJ Adema 2004 In situ tumor ablation creates an antigen source for the generation of antitumor immunity Cancer Res 64 4024 4029 10.1158/0008-5472.CAN-03-3949 (Pubitemid 38697319)
38. S Gallucci M Lolkema P Matzinger 1999 Natural adjuvants: endogenous activators of dendritic cells Nat Med 5 1249 1255 10.1038/15200 1:CAS:528:DyaK1MXnt1ynsbk%3D 10545990 (Pubitemid 29535601)
39. B Sauter ML Albert L Francisco M Larsson S Somersan N Bhardwaj 2000 Consequences of cell death: exposure to necrotic tumor cells, but not primary tissue cells or apoptotic cells, induces the maturation of immunostimulatory dendritic cells J Exp Med 191 423 434 10.1084/jem.191.3.423 1:CAS:528: DC%2BD3cXhtV2isbg%3D 10662788
40. S Basu RJ Binder R Suto KM Anderson PK Srivastava 2000 Necrotic but not apoptotic cell death releases heat shock proteins, which deliver a partial maturation signal to dendritic cells and activate the NF-kappa B pathway Int Immunol 12 1539 1546 10.1093/intimm/12.11.1539 1:CAS:528:DC%2BD3cXosVWjtbY%3D 11058573
41. P Rovere-Querini A Capobianco P Scaffidi B Valentinis F Catalanotti M Giazzon IE Dumitriu S Muller M Iannacone C Traversari ME Bianchi AA Manfredi 2004 HMGB1 is an endogenous immune adjuvant released by necrotic cells EMBO Rep 5 825 830 10.1038/sj.embor.7400205 1:CAS:528:DC%2BD2cXmtFOhur8%3D 15272298 (Pubitemid 39199174)